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Abstract
Barrier membranes are popularly used for guided bone regeneration (GBR). However, more knowledge is 
needed to assess how these membranes could be of therapeutic value when populated with native multipotent 
stromal cells (MSCs), particularly in the orthopaedic field. The present manuscript investigated the activities 
of human bone marrow-multipotent stromal cells (BM-MSCs) when loaded on two differently structured 
pure collagen membranes. A crosslinked collagen membrane (CS) was tested versus a non-crosslinked bilayer 
collagen membrane, Bio-Gide® (BG). Following loading with BM aspirate containing native MSCs, cell 
attachment to the membranes was examined using electron microscopy and flow cytometry. Furthermore, 
alkaline phosphatase (ALP) expression and calcium deposition levels were investigated for these BM-aspirate-
loaded membranes. Culture-expanded BM-MSCs were also used to load membranes and confirm the MSC 
functional data. All membranes supported BM-MSC attachment. However, larger numbers of attached BM-
MSCs were detected for CS as compared to BG (p = 0.0010). In osteogenic medium, ALP activity was higher 
for CS than BG (p = 0.0312). Total calcium deposition (not normalised to cell count) was also higher for CS than 
BG (p = 0.0073). Consistently, the normalised secreted vascular endothelial growth factor A (VEGF-A) levels 
were higher in BM-MSCs loaded on CS relative to BG (p = 0.0302). Collectively, both collagen membranes 
supported the osteogenic functions of BM-MSCs. However, CS was found to be overall superior, probably 
since it provided more BM-MSC attachment. These collagen membranes could potentially be used to improve 
GBR outcomes in orthopaedic applications.
Keywords: Bone, multipotent stromal cells, osteogenesis, repair, collagen membrane, guided bone 
regeneration.
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Introduction
Guided bone regeneration (GBR) approaches in 
orthopaedics usually involve staged surgeries 
for treating bone infections, large bone defects or 
fractures (Giannoudis et al., 2011; Masquelet and 
Begue, 2010). The Masquelet technique is an example 
of GBR surgery, where a cement spacer is used 
either as a prophylaxis or as a treatment for bone 
loss resulting from infection and tissue damage 
(Anagnostakos, 2017; Garg et al., 2011; Sivakumar et 
al., 2016). An induced membrane is a fibrous tissue 
resulting from the body reaction to the presence of 
polymethacrylate in the cement spacer. When the 
cement is removed during a second surgery, the 
empty space is packed with autograft material to 
help bone formation (Hammerle and Jung, 2003). 
The induced membrane has a vascular structure 
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similar to that of the periosteum and is highly 
enriched in multipotent stromal cells (MSCs) as well 
as osteogenic and angiogenic inductive factors, such 
as bone morphogenic protein-2 (BMP-2) and vascular 
endothelial growth factor (VEGF) (Cuthbert et al., 
2013; Giannoudis et al., 2011; Sivakumar et al., 2016). 
Despite the advantages of the induced membrane, 
this two-stage technique is usually time-consuming 
and costly (Arrington et al., 1996). Therefore, the use 
of a biocompatible membrane in a single surgical 
procedure with properties similar to that of naturally-
formed membrane would pose a real advantage 
supporting endogenous MSC functions.
 Barrier membranes have already been used 
in GBR surgeries, mainly for craniomaxillofacial 
regeneration, to enclose the repair site filled with 
bone autograft and promote faster bone healing 
(Dimitriou et al., 2012). As shown in animal studies 
and clinical applications in dental tissue regeneration, 
the composition and structure of these membranes 
could influence the efficacy of bone regeneration 
(Dimitriou et al., 2012). Bio-absorbable membranes 
made of natural materials, such as collagen and 
chitosan, show excellent biocompatibility but are 
different in their mechanical properties, with some 
having fast in vivo degradation rate. However, 
relatively rapid degradation of barrier membranes 
has been proposed as a cause of spontaneous 
periodontal healing (Elgali et al., 2017). On the other 
hand, the use of synthetic bio-absorbable membranes, 
such as aliphatic polyesters, has been associated 
with high healing rates of segmental mandibular 
defects (Elgali et al., 2017). However, such synthetic 
bio-absorbable membranes could cause moderate 
cytotoxic reactions and decrease cell adhesion (Alpar 
et al., 2000). Non-absorbable membranes, such as 
polytetrafluoroethylene, constitute another group of 
membranes that provide good mechanical support 
for cell attachment, with stable structural integrity. 
However, these membranes require a second surgery 
for removal, which increases the risk of infection (Lee 
and Kim, 2014; Marouf et al., 2000). More knowledge 
is needed to understand how these membranes and 
their structure support the bone-healing-related 
functions of human MSCs, particularly in the 
orthopaedic field.
 Collagen is the most abundant extracellular matrix 
(ECM) component in many tissues, including bone, 
supporting cell survival and functions (Hennessy et 
al., 2009; Popov et al., 2011). El-Jawhari et al. (2015) 
demonstrated that collagen incorporation within 
hydroxyapatite scaffolds significantly enhances 
attachment and proliferation of MSCs when loaded 
with bone marrow (BM) aspirates. As well as being 
highly biocompatible and flexible, collagen-based 
materials are clinically suitable for supporting tissue 
regeneration (Chevallay and Herbage, 2000; Stoppel 
et al., 2015). Collagen membranes have been assessed 
using animal models and have been found to promote 
successfully MSC attachment, growth and osteogenic 
differentiation (Li et al., 2011; Lotfi et al., 2016; Yang 
et al., 2015). These advantages have provided the 
rationale for fabricating pure collagen membranes for 
regenerative applications in maxillofacial, dental and 
neuro-surgeries (Dimitriou et al., 2012; Schwarz et al., 
2017). In contrast, using these collagen membranes 
loaded with BM aspirate containing MSCs is not yet 
popular in orthopaedic GBR treatments, although, the 
development of such novel one-stage intramuscular- 
type procedures could be highly effective.
 The purpose of the present study was to simulate 
the in vivo clinical situation and to understand further 
how native MSCs can attach to collagen membranes 
with different structures and support osteogenesis 
and angiogenesis. The membranes were loaded 
with BM aspirates to evaluate attachment, survival 
and functions of rare native bone marrow-MSCs 
(BM-MSCs), which were characterised according 
to their surface phenotype as CD45negative CD271high 
cells (Cuthbert et al., 2012; El-Jawhari et al., 2017). 
Additionally, culture-expanded BM-MSCs were used 
to confirm the biological characteristics of native 
MSCs loaded on these membranes. These included 
alkaline phosphatase (ALP) activity, mineral 
deposition and VEGF-A production/expression. 
The present study could help the understanding 
of how MSCs can promote osteogenesis when they 
colonise collagen membranes in vivo and, eventually, 
developing novel GBR approaches for large bone 
defects/fractures.
Materials and Methods
BM samples and BM-MSC isolation in culture
24 samples of BM aspirates were included in the study. 
The BM aspirates were collected from consented 
patients undergoing orthopaedic procedures in Leeds 
General Infirmary University Teaching Hospital. The 
work was carried out in accordance with the Code of 
Ethics of the World Medical Association (Declaration 
of Helsinki), National Research Ethics Committee 
Yorkshire and Humber-Leeds East (number 06/
Q1206/127). The donors included 15 males and 9 
females with an age range of 18-63 years and a median 
of 40 years. From each donor, 10 mL of BM were 
aspirated from the anterior iliac crest of the pelvis, 
always by the same surgeon (P.V. Giannoudis), as 
previously described (El-Jawhari et al., 2015). The 
isolation of BM-MSCs in culture was performed 
as described before and using the erythrocyte lysis 
technique (El-Jawhari et al., 2015; Fragakis et al. 
2018). In brief, BM aspirate samples were processed 
to remove erythrocytes using 0.86 % ammonium 
chloride solution (Vickers Laboratories, Pudsey, 
UK) and, after wash with phosphate-buffered saline 
(PBS), BM cells were seeded at 2 × 106 cells per 
2,500 mm2 flask and cultured. The StemMACS 
MSC Expansion Medium (Miltenyi Biotec, Bergisch 
Gladbach, Germany) was used to support MSC 
plastic-adhesion and proliferation. The culture 
medium was changed after 48 h, then, half-changed 
294 www.ecmjournal.org
JJ El-Jawhari et al.                                                                                    Collagen membranes support MSC functions
twice a week until 60-80 % confluency, when cells 
were detached using trypsin (Sigma-Aldrich) for 
further passage. The culture-expanded MSCs were 
used for the experiments after 3-4 passages.
Collagen membranes: loading and culture
The two membranes included in the study were 
100 % porcine collagen type I and III, ready-made 
by Geistlich Pharma, Wolhusen, Switzerland. A 
non-crosslinked collagen membrane, Bio-Gide 
(BG; 1 mm-thick) had one cell-non-permeable 
layer and another cell-permeable layer. The second 
membrane, a crosslinked collagen membrane (CS, 
6 mm thickness) was cell-permeable from all sides. To 
standardise the total surface area of both membranes, 
the original membranes were cut vertically or 
transversely in a crosswise direction at right angles 
to the long axis, while keeping the original thickness 
for both membranes. A total surface area of 60 mm2 
was set for each membrane as the standard for all 
comparisons. As recommended by the manufacturer, 
BG was soaked in the MSC expansion medium at 
37 °C 24 h before being loaded with cells.
 The loading was performed under sterile 
conditions. For each donor sample, the loading 
was performed equally for both membranes 
simultaneously. According to the experiment type, 
either the same volume of unprocessed BM aspirate 
sample [i.e. 400 μL, contained on average 4271 
CD45negative CD271high cells (range: 549-9646 cells)] or 
the same number of culture-expanded MSCs (range: 
2-3 × 105 MSCs suspended in 400 μL medium per cm2) 
were used. Carried by forceps, each membrane was 
placed flat inside a well of a 24-well plate. The loading 
was carefully applied drop by drop on the top of 
the cell permeable layer of either BG or CS surfaces. 
The membranes were left for 1, 2 or 3 h at 37 °C to 
allow for cell adherence, with gentle movement 
every 30 min to encourage further cell attachment. 
The membranes were gently washed with PBS 
before being moved into new 24-well plates, covered 
with medium and cultured for defined periods, 
according to the experiment. The StemMACS 
MSC Expansion medium or the osteogenic medium 
formed of low-glucose Dulbecco’s Modified Eagle 
Medium (DMEM), 10 % foetal calf serum (FCS), 
100 nM dexamethasone, 10 mM β-glycerophosphate 
and 0.05 mM ascorbic acid (all from Sigma-Aldrich) 
were used according to the experiment plan.
Electron and confocal microscopy
Membranes were used unloaded or loaded (with BM 
aspirate or culture-expanded BM-MSCs), then, further 
cultured in MSC expansion or osteogenic medium 
according to the experiment plan. The membranes 
were fixed in 3.7 % formaldehyde before electron 
and confocal microscopy analysis. Environmental 
scanning electron microscopy (ESEM) was used to 
examine the topography of the membrane surface 
and cell attachment following 2-week cultivation, 
using an S-3700N scanning electron microscope 
(Hitachi, Berkshire, UK) as previously described (El-
Jawhari et al., 2015). Images of the hydrated samples 
were acquired under low vacuum at – 20 °C. Mineral 
deposition (calcium/phosphorus) on the membrane 
surfaces, under osteogenic conditions, was semi-
quantitatively assessed using energy-dispersive X-ray 
spectroscopy (EDS), as reported before (Kouroupis 
et al., 2013). EDS mapping images were acquired to 
a depth of 2 mm, over an 8 min acquisition time and 
each analysis was performed in triplicate.
 For confocal imaging, the fixed membranes were 
permeabilised in 0.1 % Tween 20 for 15 min to allow 
intracellular staining. Then, the membranes were 
stained for 1 h in the dark with 0.1 % 4’,6-diamidino-
2-phenylindole (DAPI) with or without phalloidin 
(1 μg/mL in PBS), which was used for actin structure 
staining (Sigma-Aldrich), and washed in PBS before 
imaging. The membranes were imaged using the 
SP8 confocal laser scanning microscope (Leica) using 
405 nm and 540 nm excitation wavelength. Images 
were captured using a 40×/0.80 W U-V-I NA water 
dipping objective (Leica).
Flow cytometry
An indirect approach using flow cytometry was 
applied for evaluating the BM-MSC attachment to the 
collagen membranes after 1, 2 or 3 h of loading with 
BM aspirates. Samples from the pre- and post-loading 
BM fractions (5 different BM aspirates) were stained 
with a haematopoietic lineage marker, CD45 (563879, 
BD Biosciences), and a native BM-MSC marker, 
CD271 (130-112-601, Miltenyi Biotec). Native BM-
MSCs were quantified as CD45negative CD271high cells, as 
reported before (Cuthbert et al., 2012; El-Jawhari et al., 
2017). The CountBright™ Absolute Counting Beads 
(Life Technologies) were used for absolute counting 
of these cells, according to the manufacturer’s 
instructions. The number of CD45negative CD271high 
cells attached to the membranes were calculated by 
subtraction of the post-loading cell number from the 
pre-loading cell number, considering pre-loading and 
post-loading BM volumes.
 Flow cytometry was also used for quantifying the 
survived BM-MSCs within the membranes after 1, 2 
or 3 weeks of culture in the expansion medium. Five 
different samples were analysed for direct counting 
of cells retrieved following membrane digestion. 
Membranes were digested using 0.25 % collagenase 
type I (07902, Stem Cell Technologies Ltd) to release 
cells, as described previously (El-Jawhari et al., 2015). 
The cell surface levels of CD271 are reduced in culture 
(Battula et al., 2009), thus, the digested cell fractions 
were stained for the known positive markers of 
culture-expanded BM-MSCs (Dominici et al., 2006), 
CD90 (MCA90F, BIO-RAD) and CD73 (130-095-182, 
Miltenyi Biotec), as well as the negative marker 
CD45. Live cells were identified using the live and 
dead cell dyes, calcein violet and aqua, respectively 
(Life Technologies). Absolute counts of live BM-
MSCs were calculated using the CountBright™ 
Absolute Counting Beads (Life Technologies). All 
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flow cytometry data were acquired on LSR-II flow 
cytometer and analysed using DIVA software (BD 
Bioscience).
BM-MSC osteogenesis assessment
Alizarin red S staining was performed to detect calcium 
deposits. BG and CS were loaded with BM aspirates 
and cultured for 3 weeks in osteogenic medium. 
Membranes were fixed in 3.7 % formaldehyde 
(Sigma-Aldrich), paraffin-wax-embedded and 
sectioned. Alizarin red S (Sigma-Aldrich) aqueous 
solution was prepared as 40 mM in distilled water at 
pH 4.1. The slides were stained for 10 min at room 
temperature, then rinsed 3 times in distilled water. 
The slides were scanned using the Aperio Digital 
Pathology Scanner (Leica) and viewed on ImageScope 
software (Leica).
 ALP activity displayed by culture-expanded BM-
MSCs (from six different donors) that were loaded 
on the membranes was measured following 2-week 
culture in osteogenic or control StemMACS MSC 
Expansion medium, as described before (Kouroupis 
et al., 2013). Membranes were lysed in 0.1× Triton-X 
solution (micelle concentration: 0.2 mM at 20 °C) and 
exposed to three cycles of freezing-thawing to release 
the cellular contents. ALP activity was measured 
using the Alkaline Phosphatase Activity colorimetric 
kit (BioVision) according to the manufacturer’s 
instructions. The measurements of ALP activity were 
normalised to DNA levels, which were calculated 
using the Quant-iT PicoGreen dsDNA Assay Kit (Life 
Technologies), as per the manufacturer’s instructions.
 Calcium assays were performed after 3 weeks 
of culture in the osteogenic or control expansion 
medium. Membranes loaded with culture-expanded 
BM-MSCs from five different donors were treated 
for 16 h at 4 °C with 0.5 M HCl solution and mild 
agitation to extract calcium. Calcium levels were 
analysed using a colorimetric kit (Calcium Liquid, 
Sentinel Diagnostics, Milan, Italy) as recommended 
by the manufacturer. The optical density readings 
for calcium and ALP assays were acquired using a 
Multiscan EX reader and analysed using Ascent™ 
software (ThermoFisher Scientific).
Enzyme-linked immunosorbent assay (ELISA) for 
VEGF-A
Secreted levels of VEGF-A were quantified in the 
culture supernatants of BM-MSC-loaded membranes 
(culture-expanded BM-MSCs from five different 
donors) after 1 and 3-week culture in either osteogenic 
or expansion medium. Culture supernatants were 
collected at these time points and kept frozen until 
analysis. VEGF-A colorimetric ELISA kit (KHG0111, 
Life Technologies) was used according to the 
manufacturer’s instructions. The optical density was 
measured using Multiscan EX reader and analysed 
using Ascent™ software (ThermoFisher Scientific). 
The effect of medium change dilution on VEGF-A 
concentration was considered during data analysis.
Quantitative PCR for lineage markers, ALP and 
VEGF
Both membranes were loaded with either fresh BM 
aspirates (from three different donors) or culture-
expanded BM-MSCs (three different cultures) for 3 h. 
Then, the loaded membranes were either cultured in 
expansion or osteogenic medium for 1 or 3 weeks. At 
each time point, membranes were washed in PBS. 
RNA was extracted directly from the membranes 
using the Single Cell RNA purification Kit (P4-0164, 
Geneflow Ltd, Lichfield, UK) by using a vortex to 
ensure cell lysis. The complementary DNA (cDNA) 
was produced from 200 μg of RNA using the Reverse 
Transcription Master Mix (FLUIDIGM UK Ltd, 
Cambridge, UK). TaqMan probes (ThermoFisher 
Scientific) for VEGF-A (HS00900058_m1), VEGF-C 
(HS01099206_m1),  CD45  [protein tyrosine 
phosphatase receptor type c (PTPRC), Hs00894734_
m1], CD73 (NT5E, Hs00159686_m1), CD90 (Thy1, 
Hs00174816_m1) and ALPL (Hs01029144_m1) were 
used for the assays. Real-time PCR assays were run 
on QuantStudio™ 7 Flex Real-Time PCR System, 384-
well (ThermoFisher Scientific). The gene expression 
levels were calculated relative to the housekeeping 
control gene, hypoxanthine guanine phosphoribosyl 
transferase (HPRT1, TaqMan probe, Hs02800695_m1) 
as previously published (Churchman et al., 2012). 
Negative controls of no RNA and no probe were 
included in each PCR run.
Statistics
Statistical analysis was performed using Prism 
software (version 7.0a; GraphPad). Comparative 
statistical tests (specified in the figure legends) were 
applied according to the normal distribution of the 
data tested using the Shapiro-Wilk normality test. All 
comparisons were paired as the same donor samples 
were used for both membranes. The difference 
between the groups was considered statistically 
significant for p < 0.05.
Results
Visualisation of BM cell attachment to the collagen 
membranes
BG and CS membranes were loaded with the 
same volume of BM aspirate sample and cultured 
for 2 weeks. Then, ESEM was used to image the 
membrane surfaces. When compared with the 
unloaded BG, flattened structures were stretched 
over the surface of the cell-permeable layer of loaded 
BG. This observation suggested the presence of cells 
attached to the membrane (Fig. 1, left). The surfaces 
of the non-permeable layer of unloaded and loaded 
BG were also examined and the collagen fibres were 
tightly arranged as compared to the permeable 
surface, preventing any cell attachment or ingrowth 
(Fig. 1, middle). Additionally, the pores of the loaded 
CS were partially or fully filled as compared to the 
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unloaded membrane (Fig. 1, right). Altogether, data 
suggested that both collagen membranes allowed 
BM cell attachment.
 BM aspirates are composed of a heterogeneous 
mixture of cells with very small numbers of MSCs 
(El-Jawhari et al., 2015). Thus, the specific BM-MSC 
attachment to the membranes was evaluated using 
confocal microscopy after loading both membranes 
with the same numbers of culture-expanded BM-
MSCs. The loaded membranes were cultured for 
2 weeks before confocal imaging. DAPI staining for 
nuclei was used to indicate the presence of BM-MSCs 
attached to collagen membranes. The unloaded BG 
and CS showed only background reflection of the 
membranes but no DAPI staining (Fig. 2a, top panels, 
left and right, respectively). In contrast, both MSC-
loaded BG and CS showed similarly positive staining 
with DAPI (Fig. 2a, lower panels, left and right, 
respectively). In addition to DAPI, phalloidin staining 
was detected, showing the actin structure of BM-
MSCs attached to both BG and CS (Fig. 2b, left and 
right, respectively). Collectively, confocal imaging 
helped to visualise and confirm the attachment of 
BM-MSCs to BG and CS membranes.
Quantification of BM-MSC attachment to the 
collagen membranes
Attachment of native BM-MSCs to the membranes 
was quantified by flow cytometry. Both membranes 
were loaded with the same BM aspirate for 1, 2 or 
3 h. Then, the number of attached BM-MSCs was 
calculated by subtraction of post-loading from pre-
loading BM-MSC numbers. For both pre-loading 
and post-loading BM aspirates, the native BM-MSCs 
were identified as being CD45negative CD271high and 
counted by flow cytometry using counting beads 
(Cuthbert et al., 2012; El-Jawhari et al., 2017). Similarly, 
other attached BM cells were counted and identified 
based on their size and CD45 expression (El-Jawhari 
et al., 2015) as CD45negative (containing MSCs as well 
as erythroid and endothelial cells), CD45positive SSC 
(Side Scatter)med/high (myeloid-monocyte lineage cells) 
and CD45positive SSClow (lymphocyte lineage cells). An 
example of this gating strategy is illustrated in Fig. 3a.
 For BM aspirates from five different donors, 
the mean number of CD45negative CD271high cells in 
400 μL of full BM aspirate (pre-loading samples) 
was 4271 cells (range: 549-9646 cells). The mean 
number of CD45negative CD271high cells in the post-
loading samples after 3 h of loading was 1767 cells 
for BG and 734 for CS (Fig. 3b, upper panel), 
indicating a successful attachment of BM-MSCs 
to both membranes. However, the trend of lower 
CD45negative CD271high cell numbers in post-loading 
samples for CS relative to BG suggested better MSC 
attachment for CS. The mean number of myeloid-
monocyte lineage cells in the pre-loading samples 
was 7.3 × 106 cells. The myeloid-monocyte lineage 
cells in the post-loading samples were counted as 
3.8 × 106 and 1 × 106 cells after 3 h of loading with 
BG and CS, respectively (Fig. 3b, upper panel). As 
well, a mean of 1.6 × 106 lymphocyte-lineage cells 
was counted in pre-loading samples and 0.9 × 106 
and 0.4 × 106 cells in post-loading samples following 
3 h of loading with BG and CS, respectively (Fig. 3b, 
upper panel). Data showed a trend of lower numbers 
Fig. 1. ESEM imaging of collagen membranes. ESEM imaging of unloaded (upper panels) and loaded 
(lower panels) membranes: surface of the cell-permeable layer of BG (left), cell-non-permeable layer of 
BG (middle) and CS (right). Membranes were loaded with 400 μL of BM aspirates for 3 h and cultured 
in expansion medium for 2 weeks and, finally, formalin-wax-fixed for imaging. Hydrated samples were 
acquired under low vacuum at – 20 °C. White arrows indicate sites of the possible cell attachment to the 
loaded membranes.
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of myeloid-monocyte and lymphocyte lineage cells in 
post-loading samples after loading CS as compared 
to BG, implying a better attachment of these cells 
to CS. Together, these findings demonstrated the 
successful attachment of different BM cells to the 
collagen membranes within a few hours of loading 
with BM aspirates and indicated some differences 
between BG and CS.
 The median percentage of CD45negative CD271high 
cells among other BM cells was 0.03 % in pre-loading 
samples and 0.026 and 0.05 % in post-loading samples 
for BG and CS, respectively (Fig. 3b, lower panel). 
Furthermore, the median percentage of myeloid-
monocyte lineage cells was 53 % and 57.3 %, in the 
pre-and post-loading sample, respectively (Fig. 3b, 
lower panel). For lymphocyte lineage cells, 15.7 % 
and 16.8 % were detected as the median percentages 
in pre- and post-loading samples, respectively (Fig. 
3b, lower panel). No statistically significant difference 
was detected for these data before and after loading. 
The comparable percentages of MSCs and other 
BM cells before and after loading of the membranes 
suggested that no BM cells, within early hours of 
incubation, preferentially attached to the membranes.
 The number of attached BM-MSCs to CS was 
similar after 1, 2 or 3 h of incubation but, for BG, 
2 h were needed (in one sample) for a larger MSC 
attachment (Fig. 3c). Donor-related variations in 
attached CD45negative CD271high cell numbers were 
observed, as reported before (Cuthbert et al., 2012; 
El-Jawhari et al., 2017). Collectively, for 1, 2, and 3 h 
of incubation, paired comparisons showed larger 
numbers of CD45negative CD271high cells attached to 
CS than BG (2.5-fold difference, p = 0.0010) (Fig. 3d). 
These data confirmed that CS was better for aiding 
the attachment of BM-MSCs than BG.
Quantification of live BM-MSCs retained on the 
collagen membranes in long-term culture
To assess how CS and BG supported long-term MSC 
survival, membranes loaded for 3 h with BM aspirates 
were cultured in expansion medium for 1, 2 or 
3 weeks before membrane digestion with collagenase. 
Cells retrieved after digestion were analysed by flow 
cytometry and live BM-MSCs were characterised as 
aqua– calcein-violet+ CD45– CD90+ CD73+ cells and 
counted using counting beads (El-Jawhari et al., 
2015). The live BM-MSC counts of three different BM 
samples, retrieved from digested membranes were 
compared after 1, 2 and 3 weeks of culture. Data 
demonstrated a steady increase over time indicative 
of MSC proliferation on both membranes; however, 
with a trend of larger MSC numbers for CS than BG 
(Fig. 4a). Analysis of the numbers of retrieved MSCs 
Fig. 2. Confocal imaging of collagen membranes. (a) Confocal images for BG (left) and CS (right) without 
loading (upper panels) or after loading with culture-expanded BM-MSCs (lower panels). Membranes were 
equally loaded for 3 h with 2-3 × 105 culture-expanded BM-MSCs per cm2 and cultured in the expansion 
medium for 2 weeks before fixation and staining with DAPI. Images for DAPI staining, reflective light or 
composite are shown for each condition. (b) Confocal images for BG (left) and CS (right) after loading with 
culture-expanded BM-MSCs. The membranes were equally loaded for 3 h with 2-3 × 105 culture-expanded 
BM-MSCs per cm2 and cultured in expansion medium for 2 weeks before fixation and staining with DAPI 
and actin. Images for DAPI (blue), actin (green) and composite staining are shown for each membrane.
298 www.ecmjournal.org
JJ El-Jawhari et al.                                                                                    Collagen membranes support MSC functions
Fig. 3. Attachment of BM aspirate cells loaded on collagen membranes. (a) Using flow cytometry, BM-
MSCs were identified as being CD45negative CD271high and other BM cells as CD45negative, CD45positive SSCmed/high 
(myeloid-monocyte-lineage cells) and CD45positive SSClow (lymphocyte lineage cells). (b) Numbers (upper 
panel) and percentages (lower panel) of native BM-MSCs, lymphocyte (Lym) and myeloid-monocyte 
lineage cells (MM) in pre-loading and post-loading BM samples (mean of 5 different samples with standard 
error). (c) Numbers of attached native BM-MSCs over three loading times (1, 2 and 3 h) for BG and CS 
(mean of 3 different samples with standard error represented). (d) Overall comparison of native BM-
MSC numbers attached to the membranes (median of 5 samples with an interquartile range represented; 
a p < 0.05; Wilcoxon matched-pairs signed rank test).
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(samples from five different donors) after 3 weeks in 
culture showed that significantly more live BM-MSCs 
were released from CS than from BG (mean of 2.5-
fold, p = 0.0039) (Fig. 4b).
 If haematopoietic-lineage cells were similarly 
retained on the collagen membranes following 
several weeks of culture was assessed. Interestingly, 
a trend of decreasing numbers of myeloid-monocyte-
lineage cells was noted when comparing cell numbers 
over 1, 2 and 3 weeks for both membranes (Fig. 4c, 
upper panel). A similar pattern of reduced numbers 
over time was detected for lymphocyte lineage cells 
(Fig. 4c, lower panel). For both cell types, more 
retained cells were found for CS than BG. Together, 
these results indicated that while MSC numbers were 
increasing with long-term culture on BG and CS, the 
numbers of haematopoietic-lineage cells decreased 
on these membranes over time.
 To further confirm the changes in the populations 
retained on the membranes, as detected by flow 
cytometry, qPCR was performed to measure gene 
expression levels of MSC (CD73 and CD90) and 
haematopoietic-lineage cell (CD45) markers over 
the long culture period. BM aspirates from three 
different donors were loaded on the membranes 
for 3 h and, then, cultured for 1 or 3 weeks. The 
transcripts levels of PTPRC (CD45) were significantly 
lower after 3-week culture as compared to 1-week 
culture for both BG and CS (p = 0.0312) (Fig. 4d), 
indicating decreased numbers of haematopoietic-
lineage cells over time in culture. In contrast, the 
transcript levels of Thy1 (CD90) and 5’-nucleotidase 
ecto [NT5E (CD73)] were significantly higher when 
measured after 3-week culture as compared to 
1-week culture and for both BG and CS (p = 0.0312, 
both markers for CS; p = 0.0328 and p = 0.0312, CD90 
and CD73, respectively, for BG) (Fig. 4d), indicating 
increased numbers of MSCs over time in culture. 
In summary, both collagen membranes supported 
survival and proliferation of BM-MSCs rather than 
Fig. 4. Survival of BM cells retained on collagen membranes after culture. (a) Numbers of live BM-MSCs 
(quantified as aqua– calcein-violet+ CD45– CD90+ CD73+ cells) retrieved after the cultured membranes were 
digested (mean of 3 different samples with standard error represented). (b) Comparison of live BM-MSC 
numbers (quantified as aqua– calcein-violet+ CD45– CD90+ CD73+ cells) retrieved after cultured membranes 
were digested (median of 5 different samples with an interquartile range represented; a p < 0.05; Wilcoxon 
matched-pairs signed rank test). (c) Numbers of live BM haemopoietic-lineage cells retrieved after the 
cultured membranes were digested (mean of 3 different samples with the standard error represented). 
(d) Gene expression levels of PTPRC, Thy1 and NST5 were measured relative to HPRT1 (median with an 
interquartile range of samples from three different donors represented; a p < 0.05; Wilcoxon matched-pairs 
signed rank test).
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haematopoietic-lineage cells. Interestingly, when 
paired comparisons were conducted, CS was found 
to outperform BG with regards to MSC long-term 
retaining/proliferation.
Effects of collagen membranes on BM-MSC 
osteogenesis
Membranes were initially assessed for their support 
to osteogenesis when colonised by native BM-
MSCs. Thus, CS and BG were similarly loaded 
with BM aspirates (three different donors) for 3 h, 
then cultured for 2 weeks in osteogenic or control 
expansion medium. Next, the gene expression levels 
of the osteogenic marker ALPL were measured. 
Interestingly, a marked, although not significant, 
increase in relative expression levels of ALPL was 
observed in BM cells cultured in osteogenic medium 
as compared to those cultured in expansion medium 
for both BG and CS (25- and 24-fold, respectively), 
with ALPL transcript levels being higher in CS than 
BG (Fig. 5a).
 Membranes were loaded with BM aspirates (two 
different donors) for 3 h and cultured for 3 weeks in 
osteogenic or control expansion medium. Then, the 
membranes were fixed and paraffin-wax-embedded. 
After cutting, sections were stained with alizarin 
red S dye to visualise calcium deposition. Both 
membranes showed red-stained nodules when 
cultured in osteogenic medium as compared to 
expansion medium (Fig. 5b). These data indicated 
successful calcium deposition in osteogenic medium 
and that both BG and CS supported the osteogenic 
differentiation of native MSCs when membranes were 
loaded with BM aspirates.
 The next step was to compare quantitatively the 
osteogenesis support offered by both BG and CS. 
However, this was limited by the low numbers of 
native MSCs in BM aspirates. Therefore, culture-
expanded BM-MSCs were used to load the collagen 
membranes for 3 h before culture in osteogenic 
medium for 2 weeks to study the activity of ALP 
by MSCs loaded on membranes. Consistently for 
all samples from six different donors, both collagen 
membranes significantly supported the culture-
expanded BM-MSC-derived ALP activity in the 
osteogenic condition as compared to the expansion 
condition (p = 0.0312) (Fig. 6a). Paired comparison 
of the ALP activity normalised to the DNA content 
between the two membranes demonstrated that CS 
supported ALP activity significantly more than BG in 
osteogenic conditions (2.5-fold, p = 0.0312) (Fig. 6b).
 To quantify calcium deposition, membranes 
were loaded for 3 h with culture-expanded BM-
MSCs and cultured for 3 weeks in osteogenic and 
F i g .  5 .  M S C  o s t e o g e n i c 
differentiation for BM-aspirate-
loaded collagen membranes. 
(a) ALPL expression levels were 
measured relative to HPRT1. BG 
and CS were initially loaded for 
3 h with 400 μL of BM aspirate 
per 60 mm2 of each membrane. 
Then, the loaded membranes were 
cultured in expansion (Expan) 
or osteogenic (Osteo) medium 
for 1 or 3 weeks (median with an 
interquartile range of samples from 
three different donors represented). 
(b) Alizarin red S staining of the 
collagen membranes. BG and 
CS were initially loaded for 3 h 
with BM aspirate, then, they were 
cultured in expansion or osteogenic 
medium for 3 weeks. Arrows show 
the areas of alizarin red S staining.
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Fig. 6. Osteogenic differentiation of culture-expanded BM-MSCs loaded on collagen membranes. (a) ALP 
activity levels of culture-expanded BM-MSCs loaded on CS and BG and cultured in expansion (E) versus 
osteogenic (O) medium (6 different samples; a p < 0.05, Wilcoxon matched-pairs signed rank test). (b) ALP 
activity normalised to DNA content (median of 6 samples with an interquartile range represented; a p < 0.05; 
Wilcoxon matched-pairs signed rank test). (c) EDS images for BG and CS loaded with culture-expanded 
BM-MSCs and cultured in osteogenic (O) medium. Scale bar: 9 μm. (d) Percentage of phosphorus (top) and 
calcium (bottom) among other elements detected using EDS for BG and CS. Mean of three samples with 
standard error is shown. (e) Total calcium levels for loaded cells as mg/mL of HCl (the same volume was 
used for extraction in all samples) (upper panel), or calcium normalised to DNA as mg of calcium/µg of 
DNA (lower panel) are shown. Bars show median with an interquartile range of samples from 5 different 
donors; a p < 0.05, paired t-test.
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control expansion medium. A map of phosphorous 
and calcium deposition on the surface of BG and 
CS was obtained by EDS (Fig. 6c), confirming 
osteogenesis support by both collagen membranes. 
The percentages of phosphorous and calcium 
deposition by culture-expanded MSCs, relative to 
the sum of other detected elements (carbon, nitrogen 
and oxygen), were also quantified. A marked increase 
in the percentage of calcium and phosphorous was 
noted after 3 weeks of osteogenic culture relative to 
expansion cultures for both BG and CS (Fig. 6d). Also, 
colorimetric calcium assays were used to quantify 
calcium deposition levels and to confirm the imaging 
data. Remarkably, calcium levels extracted from CS 
loaded with culture-expanded BM-MSC were higher 
than that of BG (mean: 575 and 381 mg/mL, p = 0.0073) 
(Fig. 6e, upper panel). However, the calcium levels 
normalised to DNA content were similar for both 
CS and BG (Fig. 6e, lower panel). Altogether, these 
results showed that both collagen membranes 
supported equally the calcium deposition by BM-
MSCs, but higher ALP activity levels were noted for 
CS.
Effect of collagen membranes on VEGF expression 
by BM-MSCs
Collagen membranes were examined for their 
support to the angiogenic functions of native MSCs. 
To address this function, collagen membranes were 
loaded with BM aspirates for 3 h and cultured in 
expansion medium for 1 or 3 weeks. Gene expression 
levels of VEGF-A, PTPRS, THY1 and NST5 were 
measured by qPCR. Comparing 3-week to 1-week 
culture, while PTPRC levels decreased and Thy1 
and NST5 increased, a trend towards increased 
levels of VEGF-A in BM cells after 3 weeks as 
compared to 1 week of culture was noted for both 
CS and BG (Fig. 7a). These data suggested that both 
collagen membranes supported the expression of the 
angiogenic factor VEGF-A in a mixture of BM cells, 
together with increased expression of MSC markers.
 To confirm the observations noted for BM 
aspirates and to use enough cells for the quantitative 
comparison of VEGF-A between BG and CS, culture-
expanded MSCs were used. The two collagen 
membranes were loaded with culture-expanded BM-
MSCs for 3 h before culturing them in expansion or 
osteogenic medium. The levels of secreted VEGF-A 
were measured in the culture supernatants after 1 
and 3 weeks by ELISA and normalised to cell number 
(samples from 5 different donors). Data demonstrated 
a consistent increase in normalised VEGF-A levels 
after 3 weeks of culture as compared to 1 week for 
both BG and CS in expansion (4.2- and 6.8-fold, 
p = 0.0102 and p = 0.0040, respectively) (Fig. 7b) and 
osteogenic medium (4.9- and 3-folds, p = 0.0036 
and p = 0.0423, respectively) (Fig. 7c). Comparing 
both culture conditions, the secreted VEGF-A levels 
(normalised to cell number) were lower in osteogenic 
cultures than in expansion cultures for BG and CS 
(Fig. 7b,c). Interestingly, paired comparisons for 
the membranes showed significantly higher levels 
of secreted normalised VEGF-A in the supernatants 
of CS as compared to BG after 3 weeks of culture in 
expansion medium (p = 0.0302) (Fig. 7b). However, 
no difference was noted between both membranes 
in osteogenic medium (Fig. 7c). In conclusion, these 
findings confirmed that both types of collagen 
membranes supported VEGF-A production by BM-
MSCs and that CS could support the secretion of 
VEGF-A, particularly from non-differentiating MSCs, 
better than BG.
 To validate the secreted VEGF-A results at the 
cellular level, the gene expression levels for VEGF-A 
and VEGF-C (the latter used to evaluate the specificity 
of VEGF-A expression levels) were measured relative 
to the housekeeping gene HPRT1. Three samples 
of culture-expanded BM-MSCs were loaded for 3 h 
on BG and CS and cultured for 1 and 3 weeks in 
expansion or osteogenic medium. Relative VEGF-C 
expression levels were consistently similar for BG and 
CS in both expansion and osteogenic conditions as 
well as between 1-week and 3-week cultures (Fig. 7d). 
In agreement with ELISA data, VEGF-A expression 
levels were significantly higher (> 2-fold difference) 
after 3 weeks than 1 week in osteogenic and 
expansion medium for both BG and CS (p = 0.0312; 
Fig. 7e). However, VEGF-A expression levels were 
consistently induced in osteogenic medium for both 
membranes as compared to expansion medium at 
week 3 (6-fold for BG and 4-fold for CS, p = 0.0312) 
(Fig. 7e). Comparing cells loaded on BG and CS, 
VEGF-A expression levels were higher for CS than 
BG when measured at 3 weeks (7-fold in expansion 
medium and 5-fold in osteogenic medium, both 
p = 0.0312) (Fig. 7e). In summary, gene expression data 
showed that VEGF-A, but not VEGF-C, expression 
was increased over time in cultures of MSC-
loaded membranes and induced particularly by 
the osteogenic medium. Additionally, expression 
levels of secreted VEGF-A and its transcripts were 
consistently higher in BM-MSCs loaded on CS than 
on BG.
Discussion
The ideal membrane intended for augmenting 
GBR therapies must be mechanically flexible and 
biocompatible to enable maximum attachment and 
functions of MSCs (Jones et al., 2016; Polo-Corrales 
et al., 2014; Yousefi et al., 2016). BG is clinically 
used for GBR surgeries of dental applications to 
prevent ingrowth of soft tissue into the healing 
site and promote the appropriate bone and blood 
vessel development (Jung et al., 2013). BG is a non-
crosslinked bilayer membrane formed of a one 
cell-non-permeable layer of tightly aligned collagen 
fibres, as shown by ESEM imaging (Fig. 1), to limit cell 
attachment and nutrient exchange. In comparison, 
the cell-permeable layer of BG allows cell ingrowth 
and nutrient/waste exchange. The second membrane 
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Fig. 7. VEGF expression by BM-MSCs loaded on collagen membranes. (a) Gene expression levels of cell 
lineage markers and VEGF-A were measured relative to HPRT1 (median with an interquartile range of 3 
readings for one BM aspirate sample). (b, c) Normalised levels per cell numbers of secreted VEGF-A in 
expansion or osteogenic culture supernatants of membranes loaded with culture-expanded BM-MSCs. 
Median with an interquartile range of samples from 5 different donors represented. a,b,c p < 0.05, one-way 
ANOVA with Tukey’s multiple comparisons test and Friedman test with Dunn’s multiple comparison test 
were used for comparisons in b and c, respectively. Gene expression levels of (d) VEGF-C and (e) VEGF-A 
relative to HPRT1 were measured in membrane-loaded BM-MSCs. Median with an interquartile range of 
samples from 3 different donors represented, Wilcoxon matched-pairs signed rank test. a,b indicate comparison 
between BG and CS; * between 1 week and 3 weeks; # between osteogenic and expansion; all indicate p < 0.05.
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analysed in the study was CS, a thicker membrane 
formed of crosslinked collagen. How BG and CS 
membranes supported the attachment and osteogenic 
functions of human BM-MSCs was comprehensively 
tested. In addition, the attachment and survival of 
native MSCs from BM aspirates on these collagen 
membranes was examined. Both collagen membranes 
loaded with BM aspirates positively supported ALPL 
expression and calcium deposition in native MSCs. 
However, because of their rarity in BM aspirates, 
it was not feasible to quantify differences between 
both membranes regarding osteogenic differentiation 
and measuring VEGF-A expression. Therefore, these 
assays were performed using larger numbers of pure 
culture-expanded BM-MSCs.
 Several dentistry-related studies have investigated 
the value of collagen-containing membranes for 
GBR, both in vitro and in vivo. For example, a nano-
electrospun bilayer collagen/chitosan membrane 
was shown to increase the osteogenic capacity 
of rabbit MSCs as assessed for calvarial defects 
(Lotfi et al., 2016). Also, natural collagenous nano-
fibrous membranes promote attachment, growth 
and osteogenic differentiation of rat or dog bone-
derived MSCs (Li et al., 2011; Yang et al., 2015). In 
contrast, the present study used human BM aspirate 
samples containing rare MSC populations as well 
as culture-expanded human BM-MSCs and tested 
their functional behaviour using various molecular 
and functional assays. Furthermore, the study 
demonstrated how small structural differences 
between the same material (i.e. collagen) could 
significantly affect attachment and, consequently, 
osteogenic functions of BM-MSCs. These data would 
contribute to a better understanding of the potential 
use of these membranes in the orthopaedic field.
 ESEM and confocal microscopy were used to 
assess the topography of the membrane surface and 
to visualise MSC attachment (Fig. 1,2). However, it 
was technically challenging to determine native MSC 
attachment by microscopy. Therefore, flow cytometry 
was used to confirm the attachment of MSCs in 
their native status (in BM aspirates). The flow-
cytometry-based method applied was adapted from a 
previously published BM-MSC phenotype, identified 
as CD45negative CD271high, and using counting beads 
(El-Jawhari et al., 2017) to quantify the attachment 
of native BM-MSCs on the collagen membranes. 
Many studies have shown that using flow cytometry 
following collagenase digestion helps characterising 
and counting cells that colonise scaffolds or naturally 
exist in human bones (Baboolal et al. 2014; El-Jawhari 
et al., 2015; El-Jawhari et al., 2017; El-Sherbiny et al., 
2018; Fragakis et al. 2018; Mirabella, et al. 2011). Both 
membranes successfully supported attachment and 
survival of BM-MSCs (Fig. 3,4). This finding agreed 
with what has been shown previously: i) the use of 
collagen-coated surfaces increases the adhesion of 
cultured human BM-MSCs (Somaiah et al., 2015); 
ii) collagen-containing scaffolds provide better 
attachment for these MSCs (El-Jawhari et al., 2015). 
The study data also indicated that other BM cells, 
including lymphocyte and myeloid-monocyte-
lineage cells, were attached to BG or CS. However, 
similar percentages of BM cells were detected in 
pre-loading and post-loading samples, indicating 
no specific preferences for cell attachment during 
the early hours of incubation with the membranes. 
In addition, the number of haematopoietic cells was 
decreased over time for both BG and CS. In order 
to confirm flow cytometry data, particularly with 
regard to the low frequency and donor-related 
variability of BM-MSC number, real-time PCR was 
performed, assessing the time-dependent growth 
of different BM cell populations on the membranes. 
Gene expression data for cell lineage markers were 
consistent with the flow cytometry observations. 
Using both flow cytometry and real-time PCR, the 
preferential retention of MSCs (CD45– CD73+ CD90+ 
cells), with a decline of haematopoietic-lineage cells 
(CD45+ population), on these collagen membranes 
was confirmed. These results were expected as 
the medium used (StemMACS MSC Expansion 
medium) is designed to support MSC expansion. 
Thus, haematopoietic-lineage cells were not or less-
attached to the membranes’ surfaces, resulting in their 
reduced survival. Additionally, the short half-life of 
the haematopoietic-lineage cells could be another 
factor causing reduced survival rates for these cell 
populations.
 Interestingly, and despite donor-related variability 
of BM-MSC numbers, CS provided more support to 
BM-MSC attachment than BG, possibly because 
of the differences in their material properties (i.e. 
thickness and crosslinking of collagen). Collagen 
crosslinking could be a contributing factor for the 
superior performance of CS. In agreement with 
this, Rowland et al. (2013) indicated that collagen 
crosslinking of porcine cartilage-derived scaffold 
can positively affect human MSC adhesion. Other 
advantages of crosslinking are preventing collagen 
contraction caused by cell proliferation and reducing 
scaffold degradation rate (Lynn et al., 2004; Mafi et 
al., 2012; Rowland et al., 2013; Shoulders and Raines, 
2009).
 Both tested collagen membranes supported the 
osteogenesis of native BM-MSCs, as shown by the 
significant increase in ALPL expression levels and 
calcium deposition when the loaded membranes 
were cultured in osteogenic medium (Fig. 5,6). These 
data agreed with previous human and animal studies 
showing that using ECM proteins, such as collagen 
and fibronectin, for scaffold fabrication enhances 
the osteogenic potential of BM and adipose-derived 
MSCs (Bernhardt et al., 2008; Chiu et al., 2012; 
Kang et al., 2013; Linsley et al., 2013; Serpooshan et 
al., 2010). Culture-expanded BM-MSCS were also 
used to load the collagen membranes, followed 
by ALP activity assays and calcium colorimetric 
assays, thus confirming previous data by using a 
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sufficient number of native MSCs. In addition, a 
further increase in the duration of the osteogenic 
experiments (by at least 3 weeks) could have 
caused membrane degradation. Distinctively, the 
structure of the collagen scaffolds could affect ALP 
activity, with CS being superior. This finding could 
be explained by the larger area of MSC-collagen 
interactions within CS (because of higher thickness as 
compared to BG). Human BM-MSCs attached to the 
collagen matrix display augmented mineralisation 
concurrent with changes in their morphology and 
increased spreading area (Chiu et al., 2012). Collagen 
crosslinking of CS could be another explanation since 
the crosslinking of collagen gel enhances rat MSC 
osteogenic differentiation (Takitoh et al., 2015). While 
total calcium deposition was larger on CS than BG, 
calcium deposition normalised to BM-MSC count 
was similar for both CS and BG, confirming the effect 
of cell attachment. Collectively, the differences in 
osteogenesis between CS and BG are likely related 
to the structural differences, i.e. thickness difference 
and, accordingly, in the number of attached/survived 
MSCs.
 VEGF-A plays a pivotal role during bone healing, 
with a paracrine influence on endothelial cells by 
boosting angiogenesis (Carlevaro et al., 2000; Hoch et 
al., 2012; Mayer et al., 2005; Street et al., 2002; Uchida 
et al., 2003). Immobilisation of VEGF-A or the use of 
a recombinant VEGF-A in collagen scaffolds augment 
angiogenesis and bone repair in animal models (Gao 
et al., 2013; Kim et al., 2016; Miyagi et al., 2011; Shen 
et al., 2008). The present study revealed that collagen 
membranes supported VEGF-A expression by human 
BM-MSCs in both expansion and differentiation 
medium (Fig. 7). These results partially agreed with 
the Mayer et al. (2005) study, which showed that 
VEGF-A secretion from human plastic-adherent BM-
MSCs is increased over time within the osteogenic 
medium. Comparing CS and BG, the secreted levels 
of VEGF-A in expansion cultures, as well as the 
gene expression levels of VEGF-A in osteogenic or 
expansion cultures, were higher in BM-MSCs attached 
to CS. These finding can be related to the differences 
in attached cell numbers; as CS was thicker than BG 
and, accordingly, CS allowed more cell attachment. 
Interestingly, the study indicated VEGF-A induction 
in differentiating MSCs; however, the measured 
levels of secreted VEGF-A were inversely lower in 
osteogenic cultures than expansion cultures. The 
disparity regarding the expression levels of gene 
and secreted VEGF-A between differentiating and 
non-differentiating MSCs could be explained by the 
various functions of VEGF-A. Secreted VEGF-A helps 
in neo-vascularisation of bone tissue that precedes 
MSC differentiation into osteoblasts and deposition of 
minerals (Sivaraj et al., 2016). In contrast, intracellular 
VEGF-A seems to have an autocrine effect on 
differentiating MSCs regulating the expression 
of transcription factors favouring osteogenic 
differentiation, as shown in an animal study by Liu 
et al. (2012). The complex regulatory mechanisms of 
VEGF expression by MSCs suggests the importance of 
MSC-mediated angiogenesis and highlights the need 
for further investigations of MSC and endothelial cell 
interactions. While the tested collagen membranes 
supported the secretion of VEGF-A by colonised 
BM-MSCs, other MSC-related factors supporting new 
vessel formation have been reported, such as basic 
fibroblast growth factor (bFGF), transforming growth 
factor beta (TGF-β), platelet-derived growth factor 
(PDGF), angiopoietin-1, placental growth factor 
(PGF), interleukin-6 (IL-6) and certain miRNAs (Gong 
et al., 2017; Tao et al., 2016). These other angiogenic 
factors are also worth investigation to reveal how 
collagen membranes loaded with BM aspirate can 
support MSCs in their angiogenic functions.
 In comparison to the two-stage induced membrane 
technique, using collagen membranes for augmenting 
antibiotic delivery would help avoiding the necessity 
for surgical insertion and removal of the cement 
spacer. Loading an absorbable type I bovine collagen 
membrane with antibiotics could reduce bacterial 
growth significantly (Cheng et al. 2015). However, 
further studies are also needed to assess in detail 
how antibiotic-loaded membranes can support MSC 
functions. Also, investigation of the functional effect 
of secreted VEGF-A on new vessel formation, e.g. by 
co-culture with endothelial cells, would be of value 
for future studies.
Conclusions
The present in vitro study demonstrated that both the 
crosslinked collagen membrane, CS, and the bilayer 
non-crosslinked membrane, BG, supported human 
BM-MSC attachment, proliferation, osteogenic 
differentiation and VEGF-A production. Differences 
in membrane thickness and, accordingly, cell 
attachment seemed to be the reason for the overall 
superior performance of CS. When loaded with 
BM aspirates containing native BM-MSCs, a 
membrane such as CS could be an attractive option 
in orthopaedics, promoting osteogenesis and 
angiogenesis in large bone defects. In contrast, a 
thinner bilayer collagen membrane such as BG could 
be potentially used as a barrier membrane with dual 
functions: the isolation of the healing area and the 
support of osteogenesis/angiogenesis. While the 
study highlighted the advantages of these collagen 
membranes, future studies using other materials 
would help understanding the collagen-specific 
effect versus other natural or synthetic materials 
for GBR orthopaedic therapies. Additionally, 
performing in vivo work would be needed to confirm 
the functional impact of inducting MSC angiogenic 
and osteogenic activities when these cells colonise 
collagen membranes in vivo.
306 www.ecmjournal.org
JJ El-Jawhari et al.                                                                                    Collagen membranes support MSC functions
Acknowledgements
This work was supported by an educational grant 
from Geistlich Pharma, Wolhusen, Switzerland [grant 
number: 101930]. The funder did not contribute to 
project design, sample collection, data analysis or 
results. The authors gratefully acknowledge the 
help given by the orthopaedic theatre team in Leeds 
General Infirmary and Heather Owston and Payal 
Ganguly for their help with sample collection. Also, 
the authors thank Jackie Hudson for her help with 
ESM and EDS. JJE is part-funded by AO Foundation 
start-up grant (grant number S-16-132E). KM is 
funded by the EPSRC Centre for Doctoral Training 
in Tissue Engineering and Regenerative Medicine – 
Innovation in Medical and Biological Engineering 
multidisciplinary collaboration of Faculties at the 
University of Leeds (grant number EP/L014823/1).
References 
 Alpar B, Leyhausen G, Gunay H, Geurtsen W 
(2000) Compatibility of resorbable and nonresorbable 
guided tissue regeneration membranes in cultures 
of primary human periodontal ligament fibroblasts 
and human osteoblast-like cells. Clin Oral Investig 4: 
219-225.
 Anagnostakos K (2017) Therapeutic use of 
antibiotic-loaded bone cement in the treatment of hip 
and knee joint infections. J Bone Jt Infect 2: 29-37.
 Arrington ED, Smith WJ, Chambers HG, Bucknell 
AL, Davino NA (1996) Complications of iliac crest 
bone graft harvesting. Clin Orthop Relat Res: 300-309.
 Baboolal TG, Boxall SA, El-Sherbiny YM, Moseley 
TA, Cuthbert RJ, Giannoudis PV, McGonagle D, Jones 
E (2014) Multipotential stromal cell abundance in 
cellular bone allograft: comparison with fresh age-
matched iliac crest bone and bone marrow aspirate. 
Regen Med 9: 593-607.
 Battula VL, Treml S, Bareiss PM, Gieseke F, 
Roelofs H, de Zwart P, Muller I, Schewe B, Skutella 
T, Fibbe WE, Kanz L, Buhring HJ (2009) Isolation 
of functionally distinct mesenchymal stem cell 
subsets using antibodies against CD56, CD271, and 
mesenchymal stem cell antigen-1. Haematologica 94: 
173-184.
 Bernhardt A, Lode A, Boxberger S, Pompe W, 
Gelinsky M (2008) Mineralised collagen – an artificial, 
extracellular bone matrix-improves osteogenic 
differentiation of bone marrow stromal cells. J Mater 
Sci Mater Med 19: 269-275.
 Carlevaro MF, Cermelli S, Cancedda R, Descalzi 
Cancedda F (2000) Vascular endothelial growth 
factor (VEGF) in cartilage neovascularization and 
chondrocyte differentiation: auto-paracrine role 
during endochondral bone formation. J Cell Sci 113: 
59-69.
 Cheng CF, Wu KM, Chen YT, Hung SL (2015) 
Bacterial adhesion to antibiotic-loaded guided 
tissue regeneration membranes -a scanning electron 
microscopy study. J Formos Med Assoc 114: 35-45.
 Chevallay B, Herbage D (2000) Collagen-
based biomaterials as 3D scaffold for cell cultures: 
applications for tissue engineering and gene therapy. 
Med Biol Eng Comput 38: 211-218.
 Chiu LH, Yeh TS, Huang HM, Leu SJ, Yang CB, 
Tsai YH (2012) Diverse effects of type II collagen 
on osteogenic and adipogenic differentiation of 
mesenchymal stem cells. J Cell Physiol 227: 2412-2420.
 Churchman SM, Ponchel F, Boxall SA, Cuthbert 
R, Kouroupis D, Roshdy T, Giannoudis PV, Emery 
P, McGonagle D, Jones EA (2012) Transcriptional 
profile of native CD271+ multipotential stromal 
cells: evidence for multiple fates, with prominent 
osteogenic and Wnt pathway signaling activity. 
Arthritis and rheumatism 64: 2632-2643.
 Crisostomo PR, Wang Y, Markel TA, Wang M, 
Lahm T, Meldrum DR (2008) Human mesenchymal 
stem cells stimulated by TNF-alpha, LPS, or hypoxia 
produce growth factors by an NF kappa B- but 
not JNK-dependent mechanism. Am J Physiol Cell 
Physiol 294: C675-682.
 Cuthbert R, Boxall SA, Tan HB, Giannoudis PV, 
McGonagle D, Jones E (2012) Single-platform quality 
control assay to quantify multipotential stromal cells 
in bone marrow aspirates prior to bulk manufacture 
or direct therapeutic use. Cytotherapy 14: 431-440.
 Cuthbert RJ, Churchman SM, Tan HB, McGonagle 
D, Jones E, Giannoudis PV (2013) Induced periosteum 
a complex cellular scaffold for the treatment of large 
bone defects. Bone 57: 484-492.
 Dimitriou R, Mataliotakis GI, Calori GM, 
Giannoudis PV (2012) The role of barrier membranes 
for guided bone regeneration and restoration of 
large bone defects: current experimental and clinical 
evidence. BMC Med 10: 81. DOI: 10.1186/1741-7015-
10-81.
 Dominici M, Le Blanc K, Mueller I, Slaper-
Cortenbach I, Marini F, Krause D, Deans R, Keating 
A, Prockop D, Horwitz E (2006) Minimal criteria for 
defining multipotent mesenchymal stromal cells. The 
International Society for Cellular Therapy position 
statement. Cytotherapy 8: 315-317.
 Elgali I, Omar O, Dahlin C, Thomsen P (2017) 
Guided bone regeneration: materials and biological 
mechanisms revisited. Eur J Oral Sci 125: 315-337.
 El-Jawhari JJ, Cuthbert R, McGonagle D, Jones E, 
Giannoudis PV (2017) The CD45lowCD271high cell 
prevalence in bone marrow samples may provide a 
useful measurement of the bone marrow quality for 
cartilage and bone regenerative therapy. J Bone Joint 
Surg Am 99: 1305-1313.
 El-Jawhari JJ, Sanjurjo-Rodriguez C, Jones E, 
Giannoudis PV (2015) Collagen-containing scaffolds 
enhance attachment and proliferation of non-cultured 
bone marrow multipotential stromal cells. J Orthop 
Res 34: 597-606.
 El-Sherbiny YM, El-Jawhari JJ ,  Moseley 
TA, McGonagle D and Jones E (2018) T cell 
immunomodulation by clinically used allogeneic 
JJ El-Jawhari et al.                                                                                    Collagen membranes support MSC functions
307 www.ecmjournal.org
human cancellous bone fragments: a potential novel 
immunotherapy tool. Sci Rep 8: 13535. DOI: 10.1038/
s41598-018-31979-1.
 Fragkakis EM, El-Jawhari JJ, Dunsmuir RA, 
Millner PA, Rao AS, Henshaw KT, Pountos I, Jones E, 
Giannoudis PV (2018) Vertebral body versus iliac crest 
bone marrow as a source of multipotential stromal 
cells: comparison of processing techniques, tri-lineage 
differentiation and application on a scaffold for spine 
fusion. PLoS One 13: e0197969. DOI: 10.1371/journal.
pone.0197969.
 Gao C, Harvey EJ, Chua M, Chen BP, Jiang F, Liu 
Y, Li A, Wang H, Henderson JE (2013) MSC-seeded 
dense collagen scaffolds with a bolus dose of VEGF 
promote healing of large bone defects. Eur Cell Mater 
26: 195-207.
 Garg P, Ranjan R, Bandyopadhyay U, Chouksey 
S, Mitra S, Gupta SK (2011) Antibiotic-impregnated 
articulating cement spacer for infected total knee 
arthroplasty. Indian J Orthop 45: 535-540.
 Giannoudis PV, Faour O, Goff T, Kanakaris N, 
Dimitriou R (2011) Masquelet technique for the 
treatment of bone defects: tips-tricks and future 
directions. Injury 42: 591-598.
 Gong M, Yu B, Wang J, Wang Y, Liu M, Paul C, 
Millard RW, Xiao DS, Ashraf M and Xu M (2017) 
Mesenchymal stem cells release exosomes that 
transfer miRNAs to endothelial cells and promote 
angiogenesis. Oncotarget 8: 45200-45212.
 Hammerle CH, Jung RE (2003) Bone augmentation 
by means of barrier membranes. Periodontol 2000 33: 
36-53.
 Hennessy KM, Pollot BE, Clem WC, Phipps MC, 
Sawyer AA, Culpepper BK, Bellis SL (2009) The effect 
of collagen I mimetic peptides on mesenchymal 
stem cell adhesion and differentiation, and on bone 
formation at hydroxyapatite surfaces. Biomaterials 
30: 1898-1909.
 Hoch AI, Binder BY, Genetos DC, Leach JK (2012) 
Differentiation-dependent secretion of proangiogenic 
factors by mesenchymal stem cells. PLoS One 7: 
e35579. DOI: 10.1371/journal.pone.0035579.
 Jones EA, Giannoudis PV, Kouroupis D (2016) 
Bone repair with skeletal stem cells: rationale, 
progress to date and clinical application. Ther Adv 
Musculoskelet Dis 8: 57-71.
 Jung RE, Fenner N, Hammerle CH, Zitzmann NU 
(2013) Long-term outcome of implants placed with 
guided bone regeneration (GBR) using resorbable 
and non-resorbable membranes after 12-14 years. 
Clin Oral Implants Res 24: 1065-1073.
 Kang BJ, Kim Y, Lee SH, Kim WH, Woo HM, Kweon 
OK (2013) Collagen I gel promotes homogenous 
osteogenic differentiation of adipose tissue-derived 
mesenchymal stem cells in serum-derived albumin 
scaffold. J Biomater Sci Polym Ed 24: 1233-1243.
 Kim JH, Kim TH, Kang MS, Kim HW (2016) 
Angiogenic effects of collagen/mesoporous 
nanoparticle composite scaffold delivering 
VEGF165. Biomed Res Int 2016: 9676934. DOI: 
10.1155/2016/9676934.
 Kouroupis D, Baboolal TG, Jones E, Giannoudis 
PV (2013) Native multipotential stromal cell 
colonization and graft expander potential of a bovine 
natural bone scaffold. J Orthop Res 31: 1950-1958.
 Lee SW, Kim SG (2014) Membranes for the guided 
bone regeneration. Maxillofac Plast Reconstr Surg 36: 
239-246.
 Li X, Chen SL, Huang DY, Zhu SX and Wang 
JL (2011) Maxillary sinus augmentation with 
simultaneous implantation using guided bone 
regeneration. Zhonghua Kou Qiang Yi Xue Za Zhi 
46: 547-550.
 Linsley C, Wu B, Tawil B (2013) The effect of 
fibrinogen, collagen type I, and fibronectin on 
mesenchymal stem cell growth and differentiation 
into osteoblasts. Tissue Eng Part A 19: 1416-1423.
 Liu Y, Berendsen AD, Jia S, Lotinun S, Baron 
R, Ferrara N, Olsen BR (2012) Intracellular VEGF 
regulates the balance between osteoblast and 
adipocyte differentiation. J Clin Invest 122: 3101-3113.
 Lotfi G, Shokrgozar MA, Mofid R, Abbas FM, 
Ghanavati F, Baghban AA, Yavari SK, Pajoumshariati 
S (2016) Biological evaluation (in vitro and in vivo) 
of bilayer collagenous coated (nano electrospun 
and solid wall) chitosan membrane for periodontal 
guided bone regeneration. Ann Biomed Eng 44: 2132-
2144.
 Lynn AK, Yannas IV, Bonfield W (2004) Antigenicity 
and immunogenicity of collagen. J Biomed Mater Res 
B Appl Biomater 71: 343-354.
 Mafi P, Hindocha S, Mafi R, Khan WS (2012) 
Evaluation of biological protein-based collagen 
scaffolds in cartilage and musculoskeletal tissue 
engineering a systematic review of the literature. 
Curr Stem Cell Res Ther 7: 302-309.
 Marouf HA, El-Guindi HM (2000) Efficacy of high-
density versus semipermeable PTFE membranes in 
an elderly experimental model. Oral Surg Oral Med 
Oral Pathol Oral Radiol Endod 89: 164-170.
 Masquelet AC, Begue T (2010) The concept of 
induced membrane for reconstruction of long bone 
defects. Orthop Clin North Am 41: 27-37.
 Mayer H, Bertram H, Lindenmaier W, Korff 
T, Weber H, Weich H (2005) Vascular endothelial 
growth factor (VEGF-A) expression in human 
mesenchymal stem cells: autocrine and paracrine role 
on osteoblastic and endothelial differentiation. J Cell 
Biochem 95: 827-839.
 Mirabella T, Poggi A, Scaranari M, Mogni M, 
Lituania M, Baldo C, Cancedda R, Gentili C (2011) 
Recruitment of host’s progenitor cells to sites of 
human amniotic fluid stem cells implantation. 
Biomaterials 32: 4218-4227.
 Miyagi Y, Chiu LL, Cimini M, Weisel RD, Radisic 
M, Li RK (2011) Biodegradable collagen patch with 
covalently immobilized VEGF for myocardial repair. 
Biomaterials 32: 1280-1290.
 Polo-Corrales L, Latorre-Esteves M, Ramirez-Vick 
JE (2014) Scaffold design for bone regeneration. J 
Nanosci Nanotechnol 14: 15-56.
308 www.ecmjournal.org
JJ El-Jawhari et al.                                                                                    Collagen membranes support MSC functions
 Popov C, Radic T, Haasters F, Prall WC, Aszodi A, 
Gullberg D, Schieker M, Docheva D (2011) Integrins 
alpha2beta1 and alpha11beta1 regulate the survival 
of mesenchymal stem cells on collagen I. Cell Death 
Dis 2: e186. DOI: 10.1038/cddis.2011.71.
 Rowland CR, Lennon DP, Caplan AI, Guilak 
F (2013) The effects of crosslinking of scaffolds 
engineered from cartilage ECM on the chondrogenic 
differentiation of MSCs. Biomaterials 34: 5802-5812.
 Schwarz F, Schmucker A, Becker J (2017) Long-
term outcomes of simultaneous guided bone 
regeneration using native and cross-linked collagen 
membranes after 8 years. Clin Oral Implants Res 28: 
779-784.
 Serpooshan V, Julien M, Nguyen O, Wang H, Li 
A, Muja N, Henderson JE, Nazhat SN (2010) Reduced 
hydraulic permeability of three-dimensional collagen 
scaffolds attenuates gel contraction and promotes 
the growth and differentiation of mesenchymal stem 
cells. Acta Biomater 6: 3978-3987.
 Shen YH, Shoichet MS, Radisic M (2008) Vascular 
endothelial growth factor immobilized in collagen 
scaffold promotes penetration and proliferation of 
endothelial cells. Acta Biomater 4: 477-489.
 Shoulders MD, Raines RT (2009) Collagen 
structure and stability. Annu Rev Biochem 78: 929-
958.
 Sivakumar R, Mohideen MG, Chidambaram 
M, Vinoth T, Singhi PK, Somashekar V (2016) 
Management of large bone defects in diaphyseal 
fractures by induced membrane formation by 
Masquelet’s technique. J Orthop Case Rep 6: 59-62.
 Sivaraj KK, Adams RH (2016) Blood vessel 
formation and function in bone. Development 143: 
2706-2715.
 Somaiah C, Kumar A, Mawrie D, Sharma A, Patil 
SD, Bhattacharyya J, Swaminathan R, Jaganathan BG 
(2015) Collagen promotes higher adhesion, survival 
and proliferation of mesenchymal stem cells. PLoS 
One 10: e0145068. DOI: 10.1371/journal.pone.0145068.
 Stoppel WL, Ghezzi CE, McNamara SL, Black 
LD, 3rd, Kaplan DL (2015) Clinical applications of 
naturally derived biopolymer-based scaffolds for 
regenerative medicine. Ann Biomed Eng 43: 657-680.
 Street J, Bao M, deGuzman L, Bunting S, Peale 
FV, Jr., Ferrara N, Steinmetz H, Hoeffel J, Cleland 
JL, Daugherty A, van Bruggen N, Redmond HP, 
Carano RA, Filvaroff EH (2002) Vascular endothelial 
growth factor stimulates bone repair by promoting 
angiogenesis and bone turnover. Proc Natl Acad Sci 
U S A 99: 9656-9661.
 Takitoh T, Bessho M, Hirose M, Ohgushi H, Mori 
H, Hara M (2015) Gamma-cross-linked nonfibrillar 
collagen gel as a scaffold for osteogenic differentiation 
of mesenchymal stem cells. J Biosci Bioeng 119: 217-
225.
 Tao H, Han Z, Han ZC and Li Z (2016) 
Proangiogenic features of mesenchymal stem cells 
and their therapeutic applications. Stem Cells Int 
2016: 1314709. DOI: 10.1155/2016/1314709.
 Uchida S, Sakai A, Kudo H, Otomo H, Watanuki 
M, Tanaka M, Nagashima M, Nakamura T (2003) 
Vascular endothelial growth factor is expressed along 
with its receptors during the healing process of bone 
and bone marrow after drill-hole injury in rats. Bone 
32: 491-501.
 Yang M, Zhou G, Castano-Izquierdo H, Zhu 
Y and Mao C (2015) Biomineralization of natural 
collagenous nanofibrous membranes and their 
potential use in bone tissue engineering. J Biomed 
Nanotechnol 11: 447-456.
 Yousefi AM, James PF, Akbarzadeh R, Subramanian 
A, Flavin C, Oudadesse H (2016) Prospect of stem 
cells in bone tissue engineering a review. Stem Cells 
Int 2016: 6180487. DOI: 10.1155/2016/6180487.
Discussion with Reviewer
Marietta Herrmann: In this study, a one-step 
procedure for seeding fresh BM aspirate on collagen 
membranes was suggested as a GBR strategy. The 
authors demonstrated that different cell populations 
attached to the membranes, including haematopoietic 
cell populations. Could the authors speculate 
which contribution different haematopoietic cell 
populations might have in bone tissue regeneration?
Authors: Several studies indicated that haematopoietic 
cell populations have an important role during all 
three phases of normal bone regeneration following 
fracture. During the early phase, myeloid-lineage 
cells, particularly macrophages and neutrophils, 
help clearing tissue debris and prepare MSCs for 
osteogenesis (cytokine-mediated priming process) 
(Krampera, 2011; Han et al., 2014; Grassi et al., 2016; 
Tso et al., 2010, additional reference). During the 
repair phase, macrophages, T- and B-lymphocytes 
and various cytokines and growth factors produced 
by these cells are involved in conversion of soft callus 
into hard callus and formation of new blood vessels 
(El-Jawhari et al., 2016; Gong et al., 2016; Könnecke 
et al., 2014; Spiller et al., 2014, additional references). 
During the bone remodelling phase, interactions 
between macrophage-derived osteoclasts, MSC-
derived osteoblasts and, probably, Th17 lymphocytes 
are critical to achieve bone union (Cho, 2015; Huang 
et al., 2009, additional references). With the use of bio-
absorbable collagen membranes as GBR devices, the 
presence of haematopoietic cell populations within 
the membranes is probably most valuable at the early 
stages following implantation, i.e. to prime MSCs for 
osteogenesis.
 The present study showed that the BM 
haematopoietic cell populations survived within 
the membranes for a limited time in in vitro culture 
conditions. In a future study, it would be interesting 
to test if the presence of these cells has a specific 
MSC priming effect. Overall, testing the co-cultures 
of specific types of immune cells with MSCs using 
different materials will be of great importance to 
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further understand the role of haematopoietic cells in 
bone healing and to help optimise bone regenerative 
therapies.
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